COUNTERACT WHAT YOU HAVE NO CONTROL OVER – RESEARCHED ANTIDOTES FROM SCIENTISTS, VIROLOGISTS AND BIOLOGISTS.

SEPTEMBER 30, 2021

DISCLOSURE: I AM IN NO WAY SHAPE OR FORM A HEALTHCARE WORKER. THE INFORMATION AND LINKS I AM SHARING ON THIS PAGE IS WHAT I HAVE DISCOVERED THROUGH MY RESEARCH.

Taking a look at what we know.

A “Natural Doctor” with 1600 patients, most have been vaccinated. She has broken her silence and recorded her findings on the injections. Her information comes from physicians, virologists and others in the healthcare field. I cannot upload the recording onto here for reasons unknown to me, but I will list the valid points she made in her statement.

She states that after the first injection it injects a small amount of saline and a bunch of ingredients that is catastrophic to your cellular system. What that does is decreases your immune system and the ability to produce white blood cells by 50%. Eight weeks later the ability to produce more white blood cells is when the second injection is recommended, they hit white cell production ability and the immune system while it is down. In the second injection they decrease the saline and increase the harmful ingredients. So the second dose attacks your ability to make white blood cells by an additional 25%, so now your body is down 75% ability to create white blood cells. So now you have only 25% ability – wiping out 75% of your military. So then they introduce the “Booster”. The booster has 81 strands of foreign bacteria that your cells have never come across and the body does not have the anti-bodies to fight it. Then chronic inflammation sets in and goes to the areas of the persons health predisposition. So if you are a person with gut issues that is where the inflammation will attack. If you have a tumour, respiratory issues or whatever the case may be that is where the inflammation will focus on where the body hits the sympathetic nervous system which is the state of “fight or flight” chronic state with low immunity. Then when the second booster is injected with 8 strands of HIV and what that does is completely shuts off to make white blood cells altogether. Throughout this process 20%-30% of the population will die. They have 3 more boosters coming out because now the person becomes dependent on the boosters to survive just as people depend on insulin to survive. Big Pharma is looking for people who will be customers for life.

After reading the above you will now understand why Ivermectin has been kept from us and you will see how Ivermectin will help counteract the white blood cell loss.

*IVERMECTIN effectively suppresses the proliferation and metastasis of cancer cells and promotes cancer cell death at doses that are nontoxic to normal cells.•

Ivermectin shows excellent efficacy against conventional chemotherapy drug-resistant cancer cells and reverses multidrug resistance.•

Ivermectin combined with other chemotherapy drugs or targeted drugs has powerful effects on cancer.•

The structure of crosstalk centered on PAK1 kinase reveals the mechanism by which ivermectin regulates multiple signaling pathways.•

Ivermectin has been used to treat parasitic diseases in humans for many years and can quickly enter clinical trials for the treatment of tumors.

Abstract

Ivermectin is a macrolide antiparasitic drug with a 16-membered ring that is widely used for the treatment of many parasitic diseases such as river blindness, elephantiasis and scabies. Satoshi ōmura and William C. Campbell won the 2015 Nobel Prize in Physiology or Medicine for the discovery of the excellent efficacy of ivermectin against parasitic diseases. Recently, ivermectin has been reported to inhibit the proliferation of several tumor cells by regulating multiple signaling pathways. This suggests that ivermectin may be an anticancer drug with great potential. Here, we reviewed the related mechanisms by which ivermectin inhibited the development of different cancers and promoted programmed cell death and discussed the prospects for the clinical application of ivermectin as an anticancer drug for neoplasm therapy.

Graphical abstract

Ivermectin has powerful antitumor effects, including the inhibition of proliferation, metastasis, and angiogenic activity, in a variety of cancer cells. This may be related to the regulation of multiple signaling pathways by ivermectin through PAK1 kinase. On the other hand, ivermectin promotes programmed cancer cell death, including apoptosis, autophagy and pyroptosis. Ivermectin induces apoptosis and autophagy is mutually regulated. Interestingly, ivermectin can also inhibit tumor stem cells and reverse multidrug resistance and exerts the optimal effect when used in combination with other chemotherapy drugs.

REFERENCE: SCIENCE DIRECT – https://www.sciencedirect.com/science/article/abs/pii/S1043661820315152

Link to purchase Ivermectin is below. Stromectol is the Canadian label and is of course approved here in Canada. We ordered the 3mg dosage.

https://nova-rx.com/categories/Antibiotics/Stromectol?synonym=Stromectol%20(ivermectin)

Lets look at the above page one point at a time.

  1. The vaccine injection instructs the body cells to create the SARS-Cov2 spike protein. Research obtained by a group of scientists shows the COVID vaccine spike protein can travel from the injection site and accumulate in organs and tissues including the spleen, bone marrow, the liver, adrenal glands and in “quite high concentrations” in the ovaries. “We made a big mistake. We didn’t realize it until now,” said Byram Bridle, a viral immunologist and associate professor at University of Guelph, Ontario. “We thought the spike protein was a great target antigen, we never knew the spike protein itself was a toxin and was a pathogenic protein. So by vaccinating people we are inadvertently inoculating them with a toxin.” Listen to this short audio after the one minute 30 second mark. https://omny.fm/shows/on-point-with-alex-pierson/new-peer-reviewed-study-on-covid-19-vaccines-sugge The Sars-CoV-2 has a spike protein on its surface. That spike protein is what allows it to infect our bodies, Bridle explained. “That is why we have been using the spike protein in our vaccines,” Bridle said. “The vaccines we’re using get the cells in our bodies to manufacture that protein. If we can mount an immune response against that protein, in theory we could prevent this virus from infecting the body. That is the theory behind the vaccine.” “However, when studying the severe COVID-19, […] heart problems, lots of problems with the cardiovascular system, bleeding and clotting, are all associated with COVID-19,”  he added. “In doing that research, what has been discovered by the scientific community, the spike protein on its own is almost entirely responsible for the damage to the cardiovascular system, if it gets into circulation.”

When the purified spike protein is injected into the blood of research animals, they experience damage to the cardiovascular system and the protein can cross the blood-brain barrier and cause damage to the brain, Bridle explained.

The biodistribution study obtained by Bridle shows the COVID spike protein gets into the blood where it circulates for several days post-vaccination and then accumulates in organs and tissues including the spleen, bone marrow, the liver, adrenal glands and in “quite high concentrations” in the ovaries. 

“We have known for a long time that the spike protein is a pathogenic protein, Bridle said. “It is a toxin. It can cause damage in our body if it gets into circulation.

2) “Although alternate treatments are available…” They don’t want you to know about the alternate holistic treatments because Big Pharma doesn’t make the billions on these treatments.

3) The death numbers speak for themselves.

4) Adverse reactions include: Strokes, blindness, deafness, clotting, miscarriages and cardiovascular disorders.

5) They have no idea of the long term affects as it is still in the experimental stage and the drug companies are fully immune to any legal reprocussions – civil liability.

THE INGREDIENT LIST WAS OFFICIALLY RELEASED

A look at IVERMECTIN – THE NOBEL PEACE PRIZE WINNER IN 2015, discovered in Japan.

https://ivermectininfo.com

Background: 

Repurposed medicines may have a role against the SARS-CoV-2 virus. The antiparasitic ivermectin, with antiviral and anti-inflammatory properties, has now been tested in numerous clinical trials.

Areas of uncertainty: 

We assessed the efficacy of ivermectin treatment in reducing mortality, in secondary outcomes, and in chemoprophylaxis, among people with, or at high risk of, COVID-19 infection.

Data sources: 

We searched bibliographic databases up to April 25, 2021. Two review authors sifted for studies, extracted data, and assessed risk of bias. Meta-analyses were conducted and certainty of the evidence was assessed using the GRADE approach and additionally in trial sequential analyses for mortality. Twenty-four randomized controlled trials involving 3406 participants met review inclusion.

Therapeutic Advances: 

Meta-analysis of 15 trials found that ivermectin reduced risk of death compared with no ivermectin (average risk ratio 0.38, 95% confidence interval 0.19–0.73; n = 2438; I2 = 49%; moderate-certainty evidence). This result was confirmed in a trial sequential analysis using the same DerSimonian–Laird method that underpinned the unadjusted analysis. This was also robust against a trial sequential analysis using the Biggerstaff–Tweedie method. Low-certainty evidence found that ivermectin prophylaxis reduced COVID-19 infection by an average 86% (95% confidence interval 79%–91%). Secondary outcomes provided less certain evidence. Low-certainty evidence suggested that there may be no benefit with ivermectin for “need for mechanical ventilation,” whereas effect estimates for “improvement” and “deterioration” clearly favored ivermectin use. Severe adverse events were rare among treatment trials and evidence of no difference was assessed as low certainty. Evidence on other secondary outcomes was very low certainty.

Conclusions: 

Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally.

The next ANTIDOTE is from Dr. Judy Mikovits who spoke about it months ago on a broadcast – “Suramin” which is White Pine Needles – We ordered it in tincture format from stonehouseholistics.com A Canadian company. This tincture has helped my son immensely!

Below is a link from my website that contains a pertinent 9 minute video created by a Canadian doctor, Dr. Charles Hoffe. Dr. Hoffe has been suspended from hospital duty for speaking out against the vaccine. In the video he demonstrates exactly what occurs once the injection enters the body.

The very simple but necessary medication to add to the daily regiment to counteract the injection is a low dosage aspirin – 81mg – Children’s aspirin is 81mg. This counteracts the clotting. Robert Kennedy Jr. did not label the vaccine “The clot shot” for no reason.

The addition of the aspirin helped my son breathe easier. He was experiencing shortness of breath and at times felt like he could not breathe at all.

High doses of vitamin “C” will obviously help boost the immune system. The injection is attempting to break down the immune system, this is why there are so many vaccinated people in hospital at the moment. Don’t just buy off the shelf drugstore vitamin “C”, most of them are not pure and have fillers. Pure 100% Ascorbic vitamin “C” is one of the best choices.

I am also making homemade HCQ for my son, see recipe below.

I have been making and drinking this for the better part of a year now, my father and I have not even experienced a sniffle.So easy and so good!Considering there is a new “v@ri@nt” on the way, it is probably a good idea to get the burner going and start boiling and get that immune system charged up!

👇
👇
👇

Grapefruit and lemon peels boiled in tonic water, add honey to your taste and zinc, this activates the vitamin “C”.I use “Activate – Immune Complex” – those who shop at the same online shopping club I do will know how to get this amazing drink mix, loaded with Zinc and vitamin “C”After it comes to a boil I let the mixture simmer (lid is always on the pot) for up to 4 hours, sometimes longer.Let cool and pour into your favourite jugs and pitchers.

The next antidote/remedy I have not tried but a friend who had pneumonia used this method is “MMS” – See link of information below.

REFERENCE – AMERICAN JOURNAL OF THERAPEUTICS – https://journals.lww.com/americantherapeutics/fulltext/2021/08000/ivermectin_for_prevention_and_treatment_of.7.aspx?fbclid=IwAR0DYeCEjlL4MXtCGqJbhcwfWcKDAjBaHnijQluCiauEvFPYzrrbxfcgu6k

References

    1. Caly  L, 
    2. Druce  JD, 
    3. Catton  MG, et al
    . The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res 2020;178:104787. doi:10.1016/j.antiviral.2020.104787pmid:http://www.ncbi.nlm.nih.gov/pubmed/32251768PubMedGoogle Scholar
    1. Schmith  VD, 
    2. Zhou  JJ, 
    3. Lohmer  LRL
    . The Approved dose of ivermectin alone is not the ideal dose for the treatment of COVID-19. Clin Pharmacol Ther 2020. doi:doi:10.1002/cpt.1889. [Epub ahead of print: 07 May2020].pmid:http://www.ncbi.nlm.nih.gov/pubmed/32378737PubMedGoogle Scholar
    1. Zhang  X, 
    2. Song  Y, 
    3. Ci  X, et al
    . Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice. Inflamm Res 2008;57:524–9.doi:10.1007/s00011-008-8007-8pmid:http://www.ncbi.nlm.nih.gov/pubmed/19109745CrossRefPubMedGoogle Scholar
    1. Zhang  X, 
    2. Song  Y, 
    3. Xiong  H, et al
    . Inhibitory effects of ivermectin on nitric oxide and prostaglandin E2 production in LPS-stimulated RAW 264.7 macrophages. Int Immunopharmacol2009;9:354–9.doi:10.1016/j.intimp.2008.12.016pmid:http://www.ncbi.nlm.nih.gov/pubmed/19168156PubMedGoogle Scholar
    1. Capellini  I, 
    2. Venditti  C, 
    3. Barton  RA
    . Phylogeny and metabolic scaling in mammals. Ecology 2010;91:2783–93.doi:10.1890/09-0817.1pmid:http://www.ncbi.nlm.nih.gov/pubmed/20957970CrossRefPubMedWeb of ScienceGoogle Scholar
    1. Ci  X, 
    2. Li  H, 
    3. Yu  Q, et al
    . Avermectin exerts anti-inflammatory effect by downregulating the nuclear transcription factor kappa-B and mitogen-activated protein kinase activation pathway. Fundam Clin Pharmacol 2009;23:449–55.doi:10.1111/j.1472-8206.2009.00684.xpmid:http://www.ncbi.nlm.nih.gov/pubmed/19453757CrossRefPubMedGoogle Scholar
    1. Yan  S, 
    2. Ci  X, 
    3. Chen  N, et al
    . Anti-Inflammatory effects of ivermectin in mouse model of allergic asthma. Inflamm Res2011;60:589–96.doi:10.1007/s00011-011-0307-8pmid:http://www.ncbi.nlm.nih.gov/pubmed/21279416PubMedGoogle Scholar
    1. Ventre  E, 
    2. Rozières  A, 
    3. Lenief  V, et al
    . Topical ivermectin improves allergic skin inflammation. Allergy 2017;72:1212–21.doi:10.1111/all.13118pmid:http://www.ncbi.nlm.nih.gov/pubmed/28052336PubMedGoogle Scholar
    1. Andersson  U, 
    2. Ottestad  W, 
    3. Tracey  KJ
    . Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19? Mol Med 2020;26:42.doi:10.1186/s10020-020-00172-4pmid:http://www.ncbi.nlm.nih.gov/pubmed/32380958PubMedGoogle Scholar
    1. Rajter.J.C.  SM, 
    2. Fatteh  N, 
    3. Vogel  F, et al
    . Icon (ivermectin Ni COvid nineteen) study: use of ivermectin is associated with lower mortality in hospitalized patients with COVID19. medRxiv 2020.Google Scholar
    1. Gorial  FI, 
    2. Mashhadani  S, 
    3. Sayaly  HM, et al
    . Effectiveness of ivermectin as add-on therapy in COVID-19 management (pilot trial). medRxiv 2020.Google Scholar
    1. Caly  L, 
    2. Druce  JD, 
    3. Catton  MG, et al. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res 2020;178:104787. doi:10.1016/j.antiviral.2020.104787pmid:http://www.ncbi.nlm.nih.gov/pubmed/32251768PubMedGoogle Scholar
    1. Schmith  VD, 
    2. Zhou  JJ, 
    3. Lohmer  LRL. The Approved dose of ivermectin alone is not the ideal dose for the treatment of COVID-19. Clin Pharmacol Ther 2020. doi:doi:10.1002/cpt.1889. [Epub ahead of print: 07 May2020].pmid:http://www.ncbi.nlm.nih.gov/pubmed/32378737PubMedGoogle Scholar
    1. Zhang  X, 
    2. Song  Y, 
    3. Ci  X, et al. Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice. Inflamm Res 2008;57:524–9.doi:10.1007/s00011-008-8007-8pmid:http://www.ncbi.nlm.nih.gov/pubmed/19109745CrossRefPubMedGoogle Scholar
    1. Zhang  X, 
    2. Song  Y, 
    3. Xiong  H, et al. Inhibitory effects of ivermectin on nitric oxide and prostaglandin E2 production in LPS-stimulated RAW 264.7 macrophages. Int Immunopharmacol2009;9:354–9.doi:10.1016/j.intimp.2008.12.016pmid:http://www.ncbi.nlm.nih.gov/pubmed/19168156PubMedGoogle Scholar
    1. Capellini  I, 
    2. Venditti  C, 
    3. Barton  RA. Phylogeny and metabolic scaling in mammals. Ecology 2010;91:2783–93.doi:10.1890/09-0817.1pmid:http://www.ncbi.nlm.nih.gov/pubmed/20957970CrossRefPubMedWeb of ScienceGoogle Scholar
    1. Ci  X, 
    2. Li  H, 
    3. Yu  Q, et al. Avermectin exerts anti-inflammatory effect by downregulating the nuclear transcription factor kappa-B and mitogen-activated protein kinase activation pathway. Fundam Clin Pharmacol 2009;23:449–55.doi:10.1111/j.1472-8206.2009.00684.xpmid:http://www.ncbi.nlm.nih.gov/pubmed/19453757CrossRefPubMedGoogle Scholar
    1. Yan  S, 
    2. Ci  X, 
    3. Chen  N, et al. Anti-Inflammatory effects of ivermectin in mouse model of allergic asthma. Inflamm Res2011;60:589–96.doi:10.1007/s00011-011-0307-8pmid:http://www.ncbi.nlm.nih.gov/pubmed/21279416PubMedGoogle Scholar
    1. Ventre  E, 
    2. Rozières  A, 
    3. Lenief  V, et al. Topical ivermectin improves allergic skin inflammation. Allergy 2017;72:1212–21.doi:10.1111/all.13118pmid:http://www.ncbi.nlm.nih.gov/pubmed/28052336PubMedGoogle Scholar
    1. Andersson  U, 
    2. Ottestad  W, 
    3. Tracey  KJ. Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19? Mol Med 2020;26:42.doi:10.1186/s10020-020-00172-4pmid:http://www.ncbi.nlm.nih.gov/pubmed/32380958PubMedGoogle Scholar
    1. Rajter.J.C.  SM, 
    2. Fatteh  N, 
    3. Vogel  F, et al. Icon (ivermectin Ni COvid nineteen) study: use of ivermectin is associated with lower mortality in hospitalized patients with COVID19. medRxiv 2020.Google Scholar
    1. Gorial  FI, 
    2. Mashhadani  S, 
    3. Sayaly  HM, et al. Effectiveness of ivermectin as add-on therapy in COVID-19 management (pilot trial). medRxiv 2020.Google Scholar

Where We Go One We Go All – I hope this information is helpful, we are all in this together.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s